Office of the Chief Medical Officer
The Johnson & Johnson Office of the Chief Medical Officer (OCMO) is a global, functionally independent group of medical and scientific professionals working across Johnson & Johnson to guide excellence in product safety and development. We apply our expertise in safety science, epidemiology, and bioethics to inform evidence- and science-based product decisions that put people first. The OCMO also chairs the Pharmaceutical Development Committee, which reviews product development plans to ensure that our products address unmet needs and benefit the people who will ultimately use them.
Johnson & Johnson Chief
Medical Officers
Our Chief Medical Officers drive medical safety excellence and innovation across Johnson & Johnson.
Delivering medical safety excellence that puts people first
Driven by the needs of the people who use our products, our focus is to provide safe products for
the people who use them.
the people who use them.
Preclinical science
Preclinical science
Driving excellence in safety at Johnson & Johnson
A Q&A with Gary Eichenbaum, Ph.D., Vice President, Translational Science and Safety, Office of the Chief Medical Officer, Johnson & Johnson
Decisions through real-world data
We are leading the way in new approaches for generating high-quality and reliable real-world evidence to inform important product decisions.
Real-world data information
Real-world data information
lorem ipsum
lorem ipsum
What is real-world evidence and how does it help patients?
As Johnson & Johnson’s Vice President and Global Head of Epidemiology, Josh Gagne and his team study real-world data to further understand the safety and effectiveness of our products across many different kinds of patients and clinical environments to help inform important decisions that ultimately improve care for patients
Driving Medical Outcomes
Driving Medical Outcomes
Ethical scientific practices & policies
We champion bioethical principles to guide scientific innovation and collaborate to advance people-centric product development and responsible data sharing practices.
Innovation
Innovation
How Johnson & Johnson is helping patients through its compassionate use program
The company’s mission is to care for the world—one person at a time. Learn how Johnson & Johnson is leading the charge to improve the process by which very sick patients may apply for access to investigational medications.